PARSIPPANY, NJ--(Marketwired - May 9, 2013) - The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for RECOTHROM®, Thrombin ...

Discover comprehensive details about Thrombin Topical Bovine Origin, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The ...

February 5, 2010 — Results from 8 clinical trials show that recombinant human thrombin (rThrombin; Recothrom, ZymoGenetics, Inc) is well tolerated in several surgical settings for topical hemostasis ...

Review the side-effects of Thrombin Topical Bovine Origin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

Does re-exposure to recombinant human thrombin result in sensitization? The authors investigated this problem in 31 adult patients who had previously been exposed to recombinant human thrombin during ...

The FDA Thursday approved ZymoGenetics Inc.'s Recothrom Thrombin, the first and only recombinant, plasma-free thrombin for use as a topical hemostat. News of the approval sent shares of ZymoGenetics ...

Please provide your email address to receive an email when new articles are posted on . Based upon increased concerns about the infectious and noninfectious risks of blood transfusions, physicians are ...

Bayer will retain the Canadian license, while ZymoGenetics will look for partners in ex-U.S. territories. ZymoGenetics is regaining global promotion rights, except Canada, for Recothrom Thrombin, ...

The U.S. Food and Drug Administration today approved Evithrom (human thrombin), a blood-clotting protein used to help control bleeding during surgery. Evithrom is the first human thrombin approved ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global medical products company, is committed to advancing surgical innovation and today announced it has completed its ...

Thrombin-jmi Clinical Trials Clinical Trials In a double-blinded, controlled trial, patients were randomly assigned to receive Thrombin-JMI (n=206) or recombinant human thrombin (n=205) as adjuncts to ...